Sangamo Announces ASGCT 2024


ZF-transcription factors for Prion Disease

“Engineered zinc finger protein transcription factors potently reduce brain PrP expression and extend survival in prion-infected mice”
Bryan Zeitler et al.
This is a post-conference recording of a presentation given at the Prion 2022 conference on September 16, 2022 by Bryan Zeitler, Senior Director, Gene Regulation at Sangamo Therapeutics.